WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 1-December 2016 (data as of 18-November-2016)
Next overall update June 2017
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 6301 Infant (under 12 months) mortality rate: 672
GDP / capita (US$): 1'9341 Child (under 5 years) mortality rate: 942

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 32'527  31'628  30'683  29'727  28'809  19'702  12'068  13'211 
Births 1'081  1'081  1'083  1'087  1'092  973  627  646 
Surviving infants 1'008  1'007  1'007  1'009  1'012  882  551  536 
Pop. less than 5 years 4'950  4'967  4'994  5'019  5'028  3'938  2'340  2'475 
Pop. less than 15 years 14'325  14'192  14'017  13'808  13'569  9'568  5'800  6'071 
Female 15-49 years 7'383  7'071  6'758  6'456  6'180  4'080  2'599  2'920 

Number of reported cases

(Click for retrospective incidence data for Afghanistan)
Diphtheria
ChartChart
  84  368  1'939 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  1'154  492  430  2'787  3'013  6'532  1'609  32'455 
Mumps
ChartChart
 
Pertussis
ChartChart
  432  371  1'497  896  411  15'748 
Polio*
ChartChart
  20  28  17  46  81  120  48  880 
Rubella
ChartChart
  59  43  367  750 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  12  17  13  21  20  139  16 
Tetanus (total)**
ChartChart
  74  39  24  37  20  131  1'618 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Afghanistan)
Vaccine year result method % card seen                                                
BCG 2012  78  CES   66  97  97  89  89  83  30  30  33 
DTP1 2012  78  CES   66  99*  99*  98  99*  94  48 
DTP3 2012  60  CES   66  98  95  90  87  82  24  25 
DTP4          93 
IPV1         
HepB_BD          18 
HepB3 2012  60  CES   66  98  95  90  87  82 
Hib3 2012  60  CES   66  98  95  90  87  82 
JapEnc         
MCV1          90  88  82  81  75  27  20  11 
MCV2          60  60  56  54  48 
PCV1          99*  99* 
PCV3          89  63 
Pol3 2012  64  CES   66  97  90  90  87  82  24  25 
Rota1         
RotaC         
RCV1         
TT2plus 2011  35       91  85  63  76  75  20 
PAB         
VAD1          15 
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Afghanistan)
BCG
ChartChart
  86  86  78  78  71  30  30 
DTP1
ChartChart
  82  82  80  78  78  48  50  22 
DTP3
ChartChart
  78  75  70  67  68  24  25 
HepB3
ChartChart
  78  75  70  67  68 
HepB_BD
ChartChart
  18 
Hib3
ChartChart
  78  75  70  67  68 
IPV1
ChartChart
 
MCV1
ChartChart
  68  66  60  59  64  27  20  11 
MCV2
ChartChart
  39  39  35  33  31 
PAB
ChartChart
  70  70  65  60  60  32  13 
PCV3
ChartChart
  66  40 
Pol3
ChartChart
  77  75  70  67  68  24  25 
RCV1
ChartChart
 
RotaC
ChartChart
 

Number of districts in the country 329  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
99 
   
/
|
|
\
Greater or equal to 90% 50
From 80 to 89% 13
From 50 to 79% 26
Less than 50% 10
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB birth; No
IPV 14 weeks; Yes
Measles 9, 18 months; Yes
OPV birth; 6, 10, 14 weeks; 9 months; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
TT 1st contact; +1, +6 months; +1, +1 year; Yes CBAW

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2015-2019  2015-2019  2011-2015  2011-2015  2011-2015  2010-2015  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 61  321  321  321  321  324 

System performance

Total Nº districts in country number 329  329  329  329  329  329  329 
Nº districts with DTP3 coverage >=80% number 206  224  219  195  187  190  185 
% of districts with DTP3 coverage >=80% From 0 to 100% 63  68  67  59  57  58  56 
Nº districts with measles (MCV1) coverage >=95% number 121  145  136  111  99  93  68 
% of districts with MCV1 coverage >=95% From 0 to 100% 37  44  41  34  30  28  21 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No  No   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  No  No  No  No    Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%            

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   

Sources

 1  "The 2016 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.